Anavex Life Sciences Corp. (0HFR.L)
USD 9.08
(-3.55%)
USD 9.08
(-3.55%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 55.75 Million | 50.98 Million | 41.94 Million | 30.93 Million | 28.8 Million | 19.18 Million |
| Selling, General and Administrative Expenses | 12.03 Million | 13.07 Million | 9.01 Million | 5.85 Million | 6.84 Million | 5.98 Million |
| Research and Development Expenses | 43.71 Million | 37.91 Million | 32.98 Million | 25.23 Million | 22.26 Million | 13.34 Million |
| Other Expenses | - | 3.32 Million | -54.1 Thousand | -149.88 Thousand | -298.94 Thousand | 1.62 Million |
| Cost and Expenses | 55.75 Million | 50.98 Million | 41.94 Million | 30.93 Million | 28.8 Million | 19.18 Million |
| Operating Income | -55.75 Million | -54.39 Million | -41.92 Million | -30.75 Million | -28.75 Million | -19.18 Million |
| Interest Expense | 964 Thousand | 946.98 Thousand | - | - | 151.13 Thousand | - |
| Income Tax Expense | 7000.00 | 358.49 Thousand | 267.56 Thousand | 22.66 Thousand | 82.18 Thousand | 72.74 Thousand |
| Earnings before Tax | -47.49 Million | -47.61 Million | -37.64 Million | -26.25 Million | -26.21 Million | -17.38 Million |
| Net Income | -47.5 Million | -47.97 Million | -37.9 Million | -26.28 Million | -26.29 Million | -17.45 Million |
| Earnings Per Share Basic | -0.60 | -0.62 | -0.54 | -0.45 | -0.54 | -0.39 |
| Earnings Per Share Diluted | -0.60 | -0.62 | -0.54 | -0.45 | -0.54 | -0.39 |
| Weighted Average Shares Outstanding | 79.78 Million | 76.9 Million | 69.8 Million | 58.19 Million | 48.9 Million | 44.65 Million |
| Weighted Average Shares Outstanding (Diluted) | 79.78 Million | 76.9 Million | 69.8 Million | 58.19 Million | 48.9 Million | 44.65 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -55.75 Million | -50.94 Million | - | - | - | - |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 14.72 Million | 12.51 Million | 11.29 Million | 12.65 Million | 55.75 Million | 13.53 Million |
| Selling, General and Administrative Expenses | 2.85 Million | 2.79 Million | 2.6 Million | 2.59 Million | - | 3.24 Million |
| Research and Development Expenses | 11.87 Million | 9.72 Million | 8.68 Million | 10.06 Million | - | 10.28 Million |
| Other Expenses | 585 Thousand | - | 592 Thousand | 669.88 Thousand | 2.71 Million | 564.84 Thousand |
| Cost and Expenses | 14.72 Million | 12.51 Million | 11.29 Million | 12.65 Million | 55.75 Million | 13.53 Million |
| Operating Income | -14.72 Million | -12.51 Million | -8.53 Million | -12.65 Million | -47.49 Million | -13.53 Million |
| Interest Expense | - | - | - | -344.00 | 964 Thousand | - |
| Income Tax Expense | -593 Thousand | -367 Thousand | 85 Thousand | -63.95 Thousand | -7000.00 | 41 Thousand |
| Earnings before Tax | -12.8 Million | -10.91 Million | -8.53 Million | -10.2 Million | -47.49 Million | -11.23 Million |
| Net Income | -12.21 Million | -10.54 Million | -8.62 Million | -10.14 Million | -47.49 Million | -11.27 Million |
| Earnings Per Share Basic | -0.14 | -0.13 | -0.11 | -0.13 | - | -0.14 |
| Earnings Per Share Diluted | -0.14 | -0.13 | -0.11 | -0.13 | - | -0.14 |
| Weighted Average Shares Outstanding | 84.53 Million | 82.46 Million | 82.07 Million | 79.78 Million | 79.78 Million | 80.87 Million |
| Weighted Average Shares Outstanding (Diluted) | 84.53 Million | 82.46 Million | 82.07 Million | 79.78 Million | 79.78 Million | 80.87 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -14.72 Million | -12.51 Million | -11.44 Million | -10.02 Million | - | -11.13 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
IMMNOV
8111
0HYA
3050
GNC
3535